Innovation Pharmaceuticals Inc. Stock Price - IPIX

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Innovation Pharmaceuticals Inc. (QB) IPIX Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.03 +4.29% 0.73 0.73 0.6975 0.7 0.7 16:00:05
Bid Price Ask Price Spread Spread % News
0.7 0.73 0.03 4.11% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
98 231,894 $ 0.7101 $ 164.66k 156.25k 0.63 - 1.51
Last Trade Time Type Quantity Stock Price Currency
15:57:59 600 $0.73 USD

Innovation Pharmaceuticals Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 102.27M 140.1M $ -15.54M - -6.58 87.14M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Innovation Pharmaceuticals Inc. (QB) News

Latest IPIX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IPIX Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.670.730.660.7015131k313k183k0.068.96%
1 Month0.660.850.6450.734393k436k191k0.0710.61%
3 Months0.7150.850.640.723539k436k158k0.0152.10%
6 Months0.851.080.640.822839k840k205k-0.12-14.12%
1 Year1.441.5050.630.919139k2M229k-0.71-49.31%
3 Years2.974.930.632.071504M269k-2.24-75.42%
5 Years0.954.930.00012.061004M273k-0.22-23.16%

Innovation Pharmaceuticals Inc. (QB) Description

An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.